Clinical Trial

Utility of Lung Clearance Index Score as a Noninvasive Marker of Small Airways Disease

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
To determine the utility and sensitivity of the lung clearance index (LCI) technique as a marker of small airways disease in adults with chronic lung conditions compared to healthy adults, adjusting for age, sex and smoking status.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2017-08-02; most recent amendment 2026-04-10.
Status change: Recruiting → Active, Not Recruiting 2020-07-06
Trial Details
NCT Number NCT03241420
Lead Sponsor National Jewish Health
Conditions Chronic Lung Disease
Enrollment 600 participants
Start Date 2017-04-24
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-15